Why is the screening rate in lung cancer still low? A seven-country analysis of the factors affecting adoption

Strong evidence of lung cancer screening’s effectiveness in mortality reduction, as demonstrated in the National Lung Screening Trial (NLST) in the US and the Dutch–Belgian Randomized Lung Cancer Screening Trial (NELSON), has prompted countries to implement formal lung cancer screening programs. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Poon, Charlotte, Wilsdon, Tim, Sarwar, Iqra, Roediger, Alexander, Yuan, Megan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666168/
https://www.ncbi.nlm.nih.gov/pubmed/38026274
http://dx.doi.org/10.3389/fpubh.2023.1264342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666168/
https://www.ncbi.nlm.nih.gov/pubmed/38026274
http://dx.doi.org/10.3389/fpubh.2023.1264342

Ejemplares similares